Development of a GBP-based glycosylation analysis system

Ended Project Grant Awarded Last action

Award ID
R43GM157786
Recipient
Awarding agency
Obligated
$613,420

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date
Place of performance
Colorado, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
The surface of cells and proteins are decorated with complex polysaccharide modifications (GLYCANS) which help shape identity, function, and immunogenicity. GLYCANS have been shown to play major roles in diseases such as cancer and in the function and stability of therapeutic proteins. Research on glycan structures is challenging and expensive, requiring specialized equipment and large amounts of samples to obtain functional structural isomeric information. Using glycan binding proteins to assay glycan structure is a rapid and affordable option for glycan isomeric structural analysis but there is no software capable of providing automated analysis of the data. To meet this need, two groups with a history of implementing transformative glycan assay and software solutions will improve upon glycan binding assays offered by Z biotech LLC and optimize the glycan structure analysis with a prototype software developed by the haab laboratory. Preliminary analysis with the software has already demonstrated remarkable ability to predict glycan structural features from purified glycoproteins and biological samples but has revealed limitations that this work will address. In the phase I of this sbir project, we will address these limitations in three aims: 1) we will supplement and improve the available data used for predicting binding by collecting a large glycan array dataset with a wide dynamic range for accurate estimates of binding affinity; 2) we will expand our coverage of glycan epitopes by supplementing with additional lectins and antibodies; 3) we will optimize the algorithm for different glycan binding assays by using control GLYCANS to account for phase shifts in affinity specific to the platform. This work will transform glycan structure analysis by offering a new low-cost glycan isomeric structure analysis platform which will open up new opportunities for clinical and pharmaceutical research.

Transactions

Action Obligated Date
Amendment $0
Amendment $306,710
Original award $306,710

Quick answers

Who received award R43GM157786?

R43GM157786 was awarded to Z Biotech, LLC by National Institute of General Medical Sciences (National Institutes of Health) on January 1, 2025.

How much is award R43GM157786 worth?

$613,420 has been obligated on R43GM157786.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login